2730-6011

Discover Oncology

Springer-Verlag

View prefix report (10.1007)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 4389 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact4389 DOIs
2

Add abstracts to 3740 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3740 DOIs
3

Deposit reference lists for 349 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact349 DOIs

DOIs for this ISSN

Showing the top 5 of 4987 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Next-generation sequencing in cancer diagnosis and treatment… (10.1007/s12672-025-01816-9)
Abstract ORCID
93.17 72
2 Modulation of the PI3K/Akt signaling pathway by resveratrol… (10.1007/s12672-025-02471-w)
Abstract ORCID
84.06 47
3 Glioblastoma multiforme: an updated overview of temozolomide… (10.1007/s12672-025-02567-3)
Abstract ORCID
83.60 46
4 Integrative transcriptomic and single-cell analysis reveals… (10.1007/s12672-025-02811-w)
Abstract ORCID
83.14 45
5 Diffuse large B cell lymphoma (DLBCL): epidemiology, pathoph… (10.1007/s12672-025-01958-w)
Abstract ORCID
82.66 44
6 Single-cell RNA sequencing explored potential therapeutic ta… (10.1007/s12672-024-01286-5)
Abstract ORCID
80.10 39
7 Circadian rhythms and cancer: implications for timing in the… (10.1007/s12672-024-01643-4)
Abstract ORCID
79.55 38
8 Welcome from the new Discover Oncology journal (10.1007/s12672-021-00395-9)
Abstract References ORCID
75.00 9
9 Gut commensal Alistipes as a potential pathogenic factor in… (10.1007/s12672-024-01393-3)
Abstract ORCID
74.57 30
10 Association of DBNDD1 with prognostic and immune biomarkers… (10.1007/s12672-025-01990-w)
Abstract ORCID
74.57 30
11 Application of artificial intelligence in medical imaging fo… (10.1007/s12672-025-03307-3)
Abstract ORCID
74.57 30
12 Advances in the regulation of macrophage polarization by the… (10.1007/s12672-025-03258-9)
Abstract ORCID
73.86 29
13 Elevated BEAN1 expression correlates with poor prognosis, im… (10.1007/s12672-024-01321-5)
Abstract ORCID
72.36 27
14 Nanotechnology-based drug delivery system for the diagnosis… (10.1007/s12672-025-02062-9)
Abstract ORCID
71.57 26
15 Mitochondrial-related drug resistance lncRNAs as prognostic… (10.1007/s12672-024-01690-x)
Abstract ORCID
70.75 25
16 SIGLEC1 has the potential to be an immune-related prognostic… (10.1007/s12672-025-02093-2)
Abstract ORCID
70.75 25
17 Visualization analysis of breast cancer-related ubiquitinati… (10.1007/s12672-025-02032-1)
Abstract ORCID
69.90 24
18 Integrated bioinformatics analysis identifies ALDH18A1 as a… (10.1007/s12672-024-01698-3)
Abstract ORCID
69.01 23
19 Exploring the therapeutic potential of cannabinoids in cance… (10.1007/s12672-024-01356-8)
Abstract ORCID
68.09 22
20 The two-sided battlefield of tumour-associated macrophages i… (10.1007/s12672-024-01464-5)
Abstract ORCID
68.09 22
21 Mushroom-derived bioactive compounds pharmacological propert… (10.1007/s12672-025-02371-z)
Abstract ORCID
68.09 22
22 CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signali… (10.1007/s12672-024-01225-4)
Abstract ORCID
67.12 21
23 Trimethylamine N-oxide promotes the proliferation and migrat… (10.1007/s12672-024-01178-8)
Abstract ORCID
66.11 20
24 Stereotactic body radiation therapy (SBRT) increases anti-PD… (10.1007/s12672-025-02914-4)
Abstract ORCID
66.11 20
25 Advancements and limitations in traditional anti-cancer ther… (10.1007/s12672-025-02198-8)
ORCID
65.43 413
26 Recent advances in early detection of nasopharyngeal carcino… (10.1007/s12672-024-01242-3)
Abstract ORCID
65.05 19
27 Recent advances in ctDNA detection using electrochemical bio… (10.1007/s12672-024-01365-7)
Abstract ORCID
65.05 19
28 Exploring the role of oral bacteria in oral cancer: a narrat… (10.1007/s12672-025-01998-2)
Abstract ORCID
63.94 18
29 Intratumoral microbiota of pancreatic ductal adenocarcinoma… (10.1007/s12672-024-01320-6)
Abstract ORCID
62.76 17
30 Current insights and future directions of Li-Fraumeni syndro… (10.1007/s12672-024-01435-w)
Abstract ORCID
62.76 17
31 Environmental factors inducing gastric cancer: insights into… (10.1007/s12672-025-01771-5)
Abstract ORCID
62.76 17
32 Probiotics in colorectal cancer prevention and therapy: mech… (10.1007/s12672-025-01996-4)
Abstract ORCID
62.76 17
33 The current landscape of artificial intelligence in computat… (10.1007/s12672-025-02212-z)
Abstract ORCID
62.76 17
34 Tumor-infiltrating nerves: unraveling the role of cancer neu… (10.1007/s12672-025-02827-2)
Abstract ORCID
62.76 17
35 Deciphering the impact of aggregated autophagy-related genes… (10.1007/s12672-024-01322-4)
Abstract ORCID
61.52 16
36 Current advances on the role of ferroptosis in tumor immune… (10.1007/s12672-024-01573-1)
Abstract ORCID
61.52 16
37 Antibody–drug conjugates treatment of small cell lung cancer… (10.1007/s12672-024-01171-1)
Abstract ORCID
60.21 15
38 CCL17, CCL22 and their receptor CCR4 in hematologic malignan… (10.1007/s12672-024-01210-x)
Abstract ORCID
60.21 15
39 MicroRNA-mediated autophagy and drug resistance in cancer: m… (10.1007/s12672-024-01525-9)
Abstract ORCID
60.21 15
40 Advances in the relationship between AP-1 and tumorigenesis,… (10.1007/s12672-025-01783-1)
Abstract ORCID
60.21 15
41 Distant metastasis of oral squamous cell carcinoma: immune e… (10.1007/s12672-025-01997-3)
Abstract ORCID
60.21 15
42 Automatic melanoma and non-melanoma skin cancer diagnosis us… (10.1007/s12672-025-02279-8)
Abstract ORCID
60.21 15
43 mRNA vaccines and SiRNAs targeting cancer immunotherapy: cha… (10.1007/s12672-025-03070-5)
Abstract ORCID
60.21 15
44 Codonopsis pilosula polysaccharide suppresses the progressio… (10.1007/s12672-024-01361-x)
Abstract ORCID
58.80 14
45 TLN1: an oncogene associated with tumorigenesis and progress… (10.1007/s12672-024-01593-x)
Abstract ORCID
58.80 14
46 Revolutionizing cancer treatment: the rise of personalized i… (10.1007/s12672-024-01638-1)
Abstract ORCID
58.80 14
47 Identification of GBN5 as a molecular biomarker of pan-cance… (10.1007/s12672-025-01840-9)
Abstract ORCID
58.80 14
48 MicroRNAs in lung cancer: their role in tumor progression, b… (10.1007/s12672-025-02054-9)
Abstract ORCID
58.80 14
49 Decoding male breast cancer: epidemiological insights, cutti… (10.1007/s12672-025-02140-y)
Abstract ORCID
58.80 14
50 Research progress on cuproptosis and copper related anti-tum… (10.1007/s12672-025-02335-3)
Abstract ORCID
58.80 14